Published :
Tables : 43
Figures : 47
Category : Healthcare
No. of Pages : 221
Report Code : HC-1155
Diagnostic Imaging Market is poised to value USD 39103.72 million by 2028 end at a CAGR of 5.7% during the forecast period 2022 to 2028. With rising consciousness about the benefits of early-stage diagnosis which has resulted in a surge for the demand for diagnostic services.This is regarded as an essential and primary growth inducer for the global medical imaging market. Factors such as rising geriatric population and access to cost-effective medical imaging systems are also making a positive impact on the market. Technological improvements are playing an important role, as it is central to the particular healthcare vertical. Hence, market players are consistently exploring and innovating to develop more efficient medical imaging devices. With the rise in geriatric population, the prevalence of chronic diseases is also on the rise. This is due to the erratic sedentary lifestyle and poor dietary patterns. Cardiovascular and cancerous ailments cause major casualties and are proven to be fatal. Early diagnosis can greatly increase patient survival rate, which is why developing countries are taking initiatives to spread awareness about medical imaging and diagnostics. Demand for diagnostic services is anticipated to grow during the forecast period due to a rise in the number of patients gaining access to medical facilities. Medical imaging will remain a pivotal area of focus for healthcare technology companies.The market is likely to witness new entrants who will explore and fund unique and novel imaging solutions.The emphasis that is being placed on the technical aspects of medical imaging has led to increased processing speed, integrating 3D and 4D imaging technology and automation among others. Such technological enhancements are favoring the adoption of medical imaging in hospitals and diagnostic centers. Globally, North America and Europe will collectively account for major market share in the diagnostic imaging systems market. This can be mainly attributed to the presence of established players, increasing adoption of telemedicine, and the rise in the prevalence of chronic diseases in these regions. The governments across the globe are running awareness programs to educate people regarding early diagnosis of chronic diseases. Such initiatives make patients aware of the early diagnosis among healthcare providers and consumers. Diagnostic imaging has helped doctors to detect diseases in the beginning, thereby improving patient survival rates. Diagnostic imaging systems improve healthcare quality and reduce healthcare costs by shortening recovery time and avoiding unnecessary invasive procedures. Such factors are playing a pivotal role in the growth of the diagnostic imaging systems market. The market is characterized by developments and strategies by main firms. For instance, in 2019, the U.S. Food and Drug Administration (USFDA) approved Siemens Healthineers’ MAGNETOM Lumina 3 Tesla MRI scanner. The system features BioMatrix patient personalization technology, which significantly improves productivity while reducing scan time. Furthermore, in 2018, Carestream Health Inc. received the USFDA 510(k) clearance for its OnSight 3D Extremity System. This imaging system uses cone beam CT technology to capture weight-bearing and other types of extremity exams. These developments fuel the market and advance it globally, thus helping it grow extensively. Major firms in the diagnostic imaging systems market are: • GE Healthcare • Siemens Healthineers • Koninklijke Philips N.V. • Canon Medical Systems Corporation • FUJIFILM Holdings Corporation • Hitachi Ltd. • Carestream Health, Inc. • Esaote S.p.A • Hologic, Inc. • Agfa-Gevaert N.V. • Samsung Electronics • Mindray Medical International • Planmed Oy • CurveBeam LLC • Shimadzu Corporation • Allengers Medical Systems • Neusoft Medical Systems • Konica Minolta, Inc. • NP, JSC Amico • Konica Minolta • SternMed • Allengers • Neusoft Medical Systems (Note: The list of the major players will be updated with the latest market scenario and trends) Diagnostic Imaging Market Segmentation: By Product • CT Scanners o Conventional CT Scanners • High-slice CT Scanners • Mid-slice CT Scanners • Low-slice CT Scanners o Cone Beam CT Systems (CBCT) • Ultrasound Systems o By Technology • 2D Ultrasound • 3D and 4D Ultrasound • Doppler Ultrasound o By Portability • Trolley/Cart-based Ultrasound Systems • Compact/Portable Ultrasound Systems • X-ray Imaging Systems o By Type • Digital X-ray Imaging Systems o Direct Radiography (DR) o Computed Radiography (CR) • Analog X-ray Imaging Systems o By Portability • Stationary Systems • Portable Systems • Magnetic Resonance Imaging (MRI) Systems o By Architecture • Closed MRI • Open MRI o By Field Strength • High and Very-high-field MRI Systems • Low-to-mid-field MRI Systems • Ultra-high-field MRI Systems • Nuclear Imaging Systems o SPECT Systems • Hybrid SPECT Systems • Standalone SPECT Systems o Hybrid PET Systems • Mammography Systems By Application • X-ray Imaging Systems o General Radiography o Dental o Fluoroscopy • MRI Systems o Brain & Neurological MRI o Spine & Musculoskeletal MRI o Vascular MRI o Pelvic & Abdominal MRI o Breast MRI o Cardiac MRI • Ultrasound Systems o Radiology/General Imaging o Cardiology o Obstetrics/Gynecology o Urology o Vascular o Other Applications • CT Scanners o Cardiology o Oncology o Neurology o Other Applications • Nuclear Imaging Systems o Cardiology o Oncology o Neurology o Other Applications • Mammography Systems By End User • Hospitals • Diagnostic Imaging Centers • Other End Users By Region • Europe • North America • APAC • Latin America • Rest of the World Competitive Landscape: ● Tier 1 players- established companies in the market with a major market share ● Tier 2 players ● Emerging players which are growing rapidly ● New Entrants FutureWise Takeaways: ● Growth prospects ● SWOT analysis ● Key trends ● Key data points affecting market growth Objectives of the Study: ● To provide an exhaustive analysis on the global diagnostic imaging market by product, by application, by end-user and by region ● To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) ● To evaluate and forecast micro-markets and the overall market ● To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the rest of the world ● To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions ● Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
With rising consciousness about the benefits of early-stage diagnosis which has resulted in a surge for the demand for diagnostic services.This is regarded as an essential and primary growth inducer for the global medical imaging market. Factors such as rising geriatric population and access to cost-effective medical imaging systems are also making a positive impact on the market. Technological improvements are playing an important role, as it is central to the particular healthcare vertical. Hence, market players are consistently exploring and innovating to develop more efficient medical imaging devices.
With the rise in geriatric population, the prevalence of chronic diseases is also on the rise. This is due to the erratic sedentary lifestyle and poor dietary patterns. Cardiovascular and cancerous ailments cause major casualties and are proven to be fatal. Early diagnosis can greatly increase patient survival rate, which is why developing countries are taking initiatives to spread awareness about medical imaging and diagnostics.
Demand for diagnostic services is anticipated to grow during the forecast period due to a rise in the number of patients gaining access to medical facilities. Medical imaging will remain a pivotal area of focus for healthcare technology companies.The market is likely to witness new entrants who will explore and fund unique and novel imaging solutions.The emphasis that is being placed on the technical aspects of medical imaging has led to increased processing speed, integrating 3D and 4D imaging technology and automation among others. Such technological enhancements are favoring the adoption of medical imaging in hospitals and diagnostic centers.
Globally, North America and Europe will collectively account for major market share in the diagnostic imaging systems market. This can be mainly attributed to the presence of established players, increasing adoption of telemedicine, and the rise in the prevalence of chronic diseases in these regions.
The governments across the globe are running awareness programs to educate people regarding early diagnosis of chronic diseases. Such initiatives make patients aware of the early diagnosis among healthcare providers and consumers. Diagnostic imaging has helped doctors to detect diseases in the beginning, thereby improving patient survival rates. Diagnostic imaging systems improve healthcare quality and reduce healthcare costs by shortening recovery time and avoiding unnecessary invasive procedures. Such factors are playing a pivotal role in the growth of the diagnostic imaging systems market.
The market is characterized by developments and strategies by main firms. For instance, in 2019, the U.S. Food and Drug Administration (USFDA) approved Siemens Healthineers’ MAGNETOM Lumina 3 Tesla MRI scanner. The system features BioMatrix patient personalization technology, which significantly improves productivity while reducing scan time. Furthermore, in 2018, Carestream Health Inc. received the USFDA 510(k) clearance for its OnSight 3D Extremity System. This imaging system uses cone beam CT technology to capture weight-bearing and other types of extremity exams. These developments fuel the market and advance it globally, thus helping it grow extensively.
Major firms in the diagnostic imaging systems market are:
• GE Healthcare • Siemens Healthineers • Koninklijke Philips N.V. • Canon Medical Systems Corporation • FUJIFILM Holdings Corporation • Hitachi Ltd. • Carestream Health, Inc. • Esaote S.p.A • Hologic, Inc. • Agfa-Gevaert N.V. • Samsung Electronics • Mindray Medical International • Planmed Oy • CurveBeam LLC • Shimadzu Corporation • Allengers Medical Systems • Neusoft Medical Systems • Konica Minolta, Inc. • NP, JSC Amico • Konica Minolta • SternMed • Allengers • Neusoft Medical Systems (Note: The list of the major players will be updated with the latest market scenario and trends)
Diagnostic Imaging Market Segmentation:
By Product • CT Scanners o Conventional CT Scanners • High-slice CT Scanners • Mid-slice CT Scanners • Low-slice CT Scanners o Cone Beam CT Systems (CBCT) • Ultrasound Systems o By Technology • 2D Ultrasound • 3D and 4D Ultrasound • Doppler Ultrasound o By Portability • Trolley/Cart-based Ultrasound Systems • Compact/Portable Ultrasound Systems • X-ray Imaging Systems o By Type • Digital X-ray Imaging Systems o Direct Radiography (DR) o Computed Radiography (CR) • Analog X-ray Imaging Systems o By Portability • Stationary Systems • Portable Systems • Magnetic Resonance Imaging (MRI) Systems o By Architecture • Closed MRI • Open MRI o By Field Strength • High and Very-high-field MRI Systems • Low-to-mid-field MRI Systems • Ultra-high-field MRI Systems • Nuclear Imaging Systems o SPECT Systems • Hybrid SPECT Systems • Standalone SPECT Systems o Hybrid PET Systems • Mammography Systems
By Application • X-ray Imaging Systems o General Radiography o Dental o Fluoroscopy • MRI Systems o Brain & Neurological MRI o Spine & Musculoskeletal MRI o Vascular MRI o Pelvic & Abdominal MRI o Breast MRI o Cardiac MRI • Ultrasound Systems o Radiology/General Imaging o Cardiology o Obstetrics/Gynecology o Urology o Vascular o Other Applications • CT Scanners o Cardiology o Oncology o Neurology o Other Applications • Nuclear Imaging Systems o Cardiology o Oncology o Neurology o Other Applications • Mammography Systems
By End User • Hospitals • Diagnostic Imaging Centers • Other End Users
By Region • Europe • North America • APAC • Latin America • Rest of the World
Competitive Landscape:
● Tier 1 players- established companies in the market with a major market share ● Tier 2 players ● Emerging players which are growing rapidly ● New Entrants
FutureWise Takeaways: ● Growth prospects ● SWOT analysis ● Key trends ● Key data points affecting market growth
Objectives of the Study: ● To provide an exhaustive analysis on the global diagnostic imaging market by product, by application, by end-user and by region ● To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) ● To evaluate and forecast micro-markets and the overall market ● To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the rest of the world ● To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions ● Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Diagnostic Imaging Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Diagnostic Imaging Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Diagnostic Imaging Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Diagnostic Imaging Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. CT Scanners 7.1.1. Conventional CT Scanners 7.1.1.1. High-slice CT Scanners 7.1.1.2. Mid-slice CT Scanners 7.1.1.3. Low-slice CT Scanners 7.1.2. Cone Beam CT Systems (CBCT) 7.2. Ultrasound Systems 7.2.1. By Technology 7.2.1.1. 2D Ultrasound 7.2.1.2. 3D and 4D Ultrasound 7.2.1.3. Doppler Ultrasound 7.2.2. By Portability 7.2.2.1. Trolley/Cart-based Ultrasound Systems 7.2.2.1. Compact/Portable Ultrasound Systems 7.3. X-ray Imaging Systems 7.3.1. By Type 7.3.1.1. Digital X-ray Imaging Systems 7.3.1.1.1. Direct Radiography Systems 7.3.1.1.2. Computed Radiography Systems 7.3.1.2. Analog X-ray Imaging Systems 7.3.2. By Portability 7.3.2.1. Stationary X-ray Imaging Systems 7.3.2.2. Portable X-ray Imaging Systems 7.4. MRI Systems 7.4.1. By Architecture 7.4.1.1. Closed MRI Systems 7.4.1.2. Open MRI Systems 7.4.2. By Field Strength 7.4.2.1. High & Very-high-field Mri Systems 7.4.2.2. Low-to-mid-field Mri Systems 7.4.2.3. Ultra-high-field Mri Systems 7.5. Nuclear Imaging Systems 7.5.1. SPECT Systems 7.5.1.1. Hybrid SPECT Systems 7.5.1.2. Standalone SPECT Systems 7.5.2. Hybrid PET Systems 7.6. Mammography Systems 8. Diagnostic Imaging Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. X-ray Imaging Systems 8.1.1. General Radiography 8.1.2. Dental 8.1.3. Fluoroscopy 8.2. MRI Systems 8.2.1. Brain & Neurological MRI 8.2.2. Spine & Musculoskeletal MRI 8.2.3. Vascular MRI 8.2.4. Pelvic & Abdominal MRI 8.2.5. Breast MRI 8.2.6. Cardiac MRI 8.3. Ultrasound Systems 8.3.1. Radiology/General Imaging 8.3.2. Cardiology 8.3.3. Obstetrics/Gynecology 8.3.4. Urology 8.3.5. Vascular 8.3.6. Other Applications 8.4. CT Scanners 8.4.1. Cardiology 8.4.2. Oncology 8.4.3. Neurology 8.4.4. Other Applications 8.5. Nuclear Imaging Systems 8.5.1. Cardiology 8.5.2. Oncology 8.5.3. Neurology 8.5.4. Other Applications 8.6. Mammography Systems 9. Diagnostic Imaging Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Hospitals 9.2. Diagnostic Imaging Centers 9.3. Other End Users 10. North America Diagnostic Imaging Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028 11. Latin America Diagnostic Imaging Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028 12. Europe Diagnostic Imaging Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028 13. Asia Pacific Diagnostic Imaging Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028 15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. GE Healthcare 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Siemens Healthineers 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Koninklijke Philips N.V. 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Canon Medical Systems Corporation 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. FUJIFILM Holdings Corporation 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Hitachi Ltd. 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Carestream Health, Inc. 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Esaote S.p.A 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Hologic, Inc. 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10.Agfa-Gevaert N.V. 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11.Samsung Electronics 16.11.1. Company Overview 16.11.2. Product Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12.Mindray Medical International 16.12.1. Company Overview 16.12.2. Product Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 16.13.Planmed Oy 16.13.1. Company Overview 16.13.2. Product Portfolio 16.13.3. SWOT Analysis 16.13.4. Financial Overview 16.13.5. Strategic Overview 16.14.CurveBeam LLC 16.14.1. Company Overview 16.14.2. Product Portfolio 16.14.3. SWOT Analysis 16.14.4. Financial Overview 16.14.5. Strategic Overview 16.15.Shimadzu Corporation 16.15.1. Company Overview 16.15.2. Product Portfolio 16.15.3. SWOT Analysis 16.15.4. Financial Overview 16.15.5. Strategic Overview 16.16.Allengers Medical Systems 16.16.1. Company Overview 16.16.2. Product Portfolio 16.16.3. SWOT Analysis 16.16.4. Financial Overview 16.16.5. Strategic Overview 16.17.Neusoft Medical Systems 16.17.1. Company Overview 16.17.2. Product Portfolio 16.17.3. SWOT Analysis 16.17.4. Financial Overview 16.17.5. Strategic Overview 16.18.Konica Minolta, Inc. 16.18.1. Company Overview 16.18.2. Product Portfolio 16.18.3. SWOT Analysis 16.18.4. Financial Overview 16.18.5. Strategic Overview 16.19.NP, JSC Amico 16.19.1. Company Overview 16.19.2. Product Portfolio 16.19.3. SWOT Analysis 16.19.4. Financial Overview 16.19.5. Strategic Overview 16.20.Konica Minolta 16.20.1. Company Overview 16.20.2. Product Portfolio 16.20.3. SWOT Analysis 16.20.4. Financial Overview 16.20.5. Strategic Overview 16.21.SternMed 16.21.1. Company Overview 16.21.2. Product Portfolio 16.21.3. SWOT Analysis 16.21.4. Financial Overview 16.21.5. Strategic Overview 16.22.Allengers 16.22.1. Company Overview 16.22.2. Product Portfolio 16.22.3. SWOT Analysis 16.22.4. Financial Overview 16.22.5. Strategic Overview 16.23.Neusoft Medical Systems 16.23.1. Company Overview 16.23.2. Product Portfolio 16.23.3. SWOT Analysis 16.23.4. Financial Overview 16.23.5. Strategic Overview 17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the healthcare regulations initiated by Koninklijke Philips N.V.inistrations 17.5. The overall economic slowdown of the developing and developed nations 18. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Diagnostic Imaging Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Diagnostic Imaging Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Diagnostic Imaging Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Diagnostic Imaging Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. CT Scanners 7.1.1. Conventional CT Scanners 7.1.1.1. High-slice CT Scanners 7.1.1.2. Mid-slice CT Scanners 7.1.1.3. Low-slice CT Scanners 7.1.2. Cone Beam CT Systems (CBCT) 7.2. Ultrasound Systems 7.2.1. By Technology 7.2.1.1. 2D Ultrasound 7.2.1.2. 3D and 4D Ultrasound 7.2.1.3. Doppler Ultrasound 7.2.2. By Portability 7.2.2.1. Trolley/Cart-based Ultrasound Systems 7.2.2.1. Compact/Portable Ultrasound Systems 7.3. X-ray Imaging Systems 7.3.1. By Type 7.3.1.1. Digital X-ray Imaging Systems 7.3.1.1.1. Direct Radiography Systems 7.3.1.1.2. Computed Radiography Systems 7.3.1.2. Analog X-ray Imaging Systems 7.3.2. By Portability 7.3.2.1. Stationary X-ray Imaging Systems 7.3.2.2. Portable X-ray Imaging Systems 7.4. MRI Systems 7.4.1. By Architecture 7.4.1.1. Closed MRI Systems 7.4.1.2. Open MRI Systems 7.4.2. By Field Strength 7.4.2.1. High & Very-high-field Mri Systems 7.4.2.2. Low-to-mid-field Mri Systems 7.4.2.3. Ultra-high-field Mri Systems 7.5. Nuclear Imaging Systems 7.5.1. SPECT Systems 7.5.1.1. Hybrid SPECT Systems 7.5.1.2. Standalone SPECT Systems 7.5.2. Hybrid PET Systems 7.6. Mammography Systems
8. Diagnostic Imaging Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. X-ray Imaging Systems 8.1.1. General Radiography 8.1.2. Dental 8.1.3. Fluoroscopy 8.2. MRI Systems 8.2.1. Brain & Neurological MRI 8.2.2. Spine & Musculoskeletal MRI 8.2.3. Vascular MRI 8.2.4. Pelvic & Abdominal MRI 8.2.5. Breast MRI 8.2.6. Cardiac MRI 8.3. Ultrasound Systems 8.3.1. Radiology/General Imaging 8.3.2. Cardiology 8.3.3. Obstetrics/Gynecology 8.3.4. Urology 8.3.5. Vascular 8.3.6. Other Applications 8.4. CT Scanners 8.4.1. Cardiology 8.4.2. Oncology 8.4.3. Neurology 8.4.4. Other Applications 8.5. Nuclear Imaging Systems 8.5.1. Cardiology 8.5.2. Oncology 8.5.3. Neurology 8.5.4. Other Applications 8.6. Mammography Systems
9. Diagnostic Imaging Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Hospitals 9.2. Diagnostic Imaging Centers 9.3. Other End Users
10. North America Diagnostic Imaging Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028
11. Latin America Diagnostic Imaging Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028
12. Europe Diagnostic Imaging Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028
13. Asia Pacific Diagnostic Imaging Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028
15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. GE Healthcare 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Siemens Healthineers 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Koninklijke Philips N.V. 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Canon Medical Systems Corporation 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. FUJIFILM Holdings Corporation 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Hitachi Ltd. 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Carestream Health, Inc. 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Esaote S.p.A 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Hologic, Inc. 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10.Agfa-Gevaert N.V. 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11.Samsung Electronics 16.11.1. Company Overview 16.11.2. Product Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12.Mindray Medical International 16.12.1. Company Overview 16.12.2. Product Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 16.13.Planmed Oy 16.13.1. Company Overview 16.13.2. Product Portfolio 16.13.3. SWOT Analysis 16.13.4. Financial Overview 16.13.5. Strategic Overview 16.14.CurveBeam LLC 16.14.1. Company Overview 16.14.2. Product Portfolio 16.14.3. SWOT Analysis 16.14.4. Financial Overview 16.14.5. Strategic Overview 16.15.Shimadzu Corporation 16.15.1. Company Overview 16.15.2. Product Portfolio 16.15.3. SWOT Analysis 16.15.4. Financial Overview 16.15.5. Strategic Overview 16.16.Allengers Medical Systems 16.16.1. Company Overview 16.16.2. Product Portfolio 16.16.3. SWOT Analysis 16.16.4. Financial Overview 16.16.5. Strategic Overview 16.17.Neusoft Medical Systems 16.17.1. Company Overview 16.17.2. Product Portfolio 16.17.3. SWOT Analysis 16.17.4. Financial Overview 16.17.5. Strategic Overview 16.18.Konica Minolta, Inc. 16.18.1. Company Overview 16.18.2. Product Portfolio 16.18.3. SWOT Analysis 16.18.4. Financial Overview 16.18.5. Strategic Overview 16.19.NP, JSC Amico 16.19.1. Company Overview 16.19.2. Product Portfolio 16.19.3. SWOT Analysis 16.19.4. Financial Overview 16.19.5. Strategic Overview 16.20.Konica Minolta 16.20.1. Company Overview 16.20.2. Product Portfolio 16.20.3. SWOT Analysis 16.20.4. Financial Overview 16.20.5. Strategic Overview 16.21.SternMed 16.21.1. Company Overview 16.21.2. Product Portfolio 16.21.3. SWOT Analysis 16.21.4. Financial Overview 16.21.5. Strategic Overview 16.22.Allengers 16.22.1. Company Overview 16.22.2. Product Portfolio 16.22.3. SWOT Analysis 16.22.4. Financial Overview 16.22.5. Strategic Overview 16.23.Neusoft Medical Systems 16.23.1. Company Overview 16.23.2. Product Portfolio 16.23.3. SWOT Analysis 16.23.4. Financial Overview 16.23.5. Strategic Overview
17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the healthcare regulations initiated by Koninklijke Philips N.V.inistrations 17.5. The overall economic slowdown of the developing and developed nations
18. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics